利妥昔单抗治疗患者乙肝再活化预防的充分性

{"title":"利妥昔单抗治疗患者乙肝再活化预防的充分性","authors":"I. Patier, N. Herranz-Muñoz, F. Fernandez Fraga, J. Sánchez-Rubio Ferrández, I. García-Bermejo, M. Moreno-García, T. Molina-García","doi":"10.1136/ejhpharm-2022-eahp.381","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":393937,"journal":{"name":"Section 7: Post Congress additions","volume":"123 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"4CPS-025 Adequacy of hepatitis B reactivation prophylaxis in patients treated with rituximab\",\"authors\":\"I. Patier, N. Herranz-Muñoz, F. Fernandez Fraga, J. Sánchez-Rubio Ferrández, I. García-Bermejo, M. Moreno-García, T. Molina-García\",\"doi\":\"10.1136/ejhpharm-2022-eahp.381\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":393937,\"journal\":{\"name\":\"Section 7: Post Congress additions\",\"volume\":\"123 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 7: Post Congress additions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2022-eahp.381\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 7: Post Congress additions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2022-eahp.381","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}